| Sector Vector | China Dumping Threat | Anti-Dumping Protection | PLI & SEZ Status | Tariff / FTA Alignment | Historical Rhyme Analogue |
|---|---|---|---|---|---|
| Power & Capital Goods | LOW IMPACT | Strict domestic content mandates for grid equipment | PLI Active (Rs 18,100 Cr) | Barriers on non-trusted equipment sources | 2003-2007 Capex Super-Cycle |
| Specialty Chemicals | MODERATE-HIGH | ADD active on key raw material imports | PCPIR & SEZ Integration | EU-REACH compliance Advantage | 2016 Environmental Crackdown Era |
| Healthcare (API / KSM) | MODERATE | Countervailing duties on bulk generic drug inputs | Bulk Drug Parks PLI | US BioSecure Act Diversion Tailwinds | 2013 Generics Approvals Surge |
| IT Services | NEGLIGIBLE | Not Applicable (Services Sector) | SEZ Sunset Clause Overhead | H-1B Visa Overhead Uncertainty | 2008 Post-GFC Tech Slowdown |
The current acceleration in heavy power equipment and capital goods firmly mimics the early phases of the 2003-2007 capex super-cycle. Domestic corporate balance sheets are lean, while sovereign capital expenditure and structured PLI schemes are expanding order books to record levels.
Capacity expansion inside SEZs is rapidly converting order visibility into revenues, insulating the sector against short-term global volatility.
Following massive capacity expansion in China, aggressive chemical dumping threatened Indian operating margins. However, targeted Anti-Dumping Policy (DGTR ADD directives) has erected a reliable pricing floor.
As global supply chains pivot toward "China+1" sourcing and bilateral FTAs unlock higher export quotas, domestic chemical margins are set for a cyclical rebound.
Domestic Active Pharmaceutical Ingredient (API) manufacturers are entering a multi-year margin expansion cycle. PLI incentives for key starting materials have systematically mitigated historical reliance on imported bulk drugs.
Current regional export volume trends rhyme with the historical 2013-2015 generic approval surge across Western markets.
A rational, data-backed approach warrants caution regarding domestic IT services. Protracted high-interest regimes in North America and Western Europe continue to delay enterprise discretionary tech budgets.
We recommend withholding allocation expansion until high-frequency global IT deal-conversion metrics demonstrate concrete bottoming signs.